Zentalis Pharmaceuticals
ZNTL
#9381
Rank
A$0.20 B
Marketcap
A$2.05
Share price
0.00%
Change (1 day)
-0.97%
Change (1 year)

Earnings for Zentalis Pharmaceuticals (ZNTL)

Earnings in 2026 (TTM): -A$0.21 Billion

According to Zentalis Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.21 Billion, an increase over its 2024 earnings that were of -A$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Zentalis Pharmaceuticals from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.21 Billion-1.08%
2025 -A$0.21 Billion-17.55%
2024 -A$0.26 Billion-40.16%
2023 -A$0.42 Billion25.12%
2022 -A$0.34 Billion34.48%
2021 -A$0.25 Billion39.33%
2020 -A$0.18 Billion154.74%
2019 -A$70.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.25 Billion 14.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$27.44 Million-86.92%๐Ÿ‡บ๐Ÿ‡ธ USA